Botanix Pharmaceuticals Limited (ASX:BOT)

Botanix Pharmaceuticals Revenue

In the fiscal year ending June 30, 2026, Botanix Pharmaceuticals had annual revenue of 33.80M AUD with 483.87% growth. Botanix Pharmaceuticals had revenue of 17.30M in the half year ending June 30, 2026, with 922.47% growth.

• Revenue: 33.80M
• Revenue Growth: +483.87%
• P/S Ratio: 1.54
• Revenue / Employee: 3.07M
• Employees: 11
• Market Cap: 52.00M

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2026	33.80M	28.01M	483.87%
Jun 30, 2025	5.79M	3.72M	179.74%
Jun 30, 2024	2.07M	-1.70M	-45.14%
Jun 30, 2023	3.77M	1.02M	36.94%
Jun 30, 2022	2.75M	-4.13M	-60.00%

Data Source: S&P Global Market Intelligence Last updated: Aug 26, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Sep 8, 2026

Data Sources Report a data error